At CEO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Columbia based CEO’ operating in the Medical space. If you think a CEO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
President & CEO of Danaher
Thomas Joyce is President and Chief Executive Officer of Danaher Corporation, a position he assumed in September 2014. Thomas is responsible for the company’s strategic vision and leads the development and growth of Danaher’s global science and technology portfolio. Thomas has more than 20 years of Danaher leadership experience. Prior to his appointment as President and Chief Executive Officer, he served as Executive Vice President of Danaher Corporation, responsible for Danaher’s Water Quality platform and Life Sciences & Diagnostics segment. In this role, Thomas increased Danaher’s Water Quality revenue by over $1.5 billion and led the company’s major acquisitions of Beckman Coulter and AB SCIEX. Throughout his tenure, Thomas has also played a key role in developing and evolving the Danaher Business System, Danaher’s common operating philosophy. Thomas began his Danaher career in 1989 as a Project Manager in the Danaher Tool Group, and later transitioned into a manufacturing role. In 1995, Thomas became President of Delta Consolidated Industries. Following this assignment, he became President of Hach Company, the world leader in analytical instrumentation for drinking water and wastewater applications in 2001. In 2002, Thomas became a Group Executive and Corporate Officer with Danaher Corporation, which led to his transition to Executive Vice President in 2006. Prior to joining Danaher, Thomas worked as a management consultant at Anderson Consulting, where he worked with a large number of manufacturing businesses to implement lean tools and optimize transactional processes. Thomas was born and raised on the north shore of Chicago and earned his bachelor’s degree in Economics from the College of the Holy Cross in 1982. He and his wife, Claire, live in Washington, D.C. and have four children.
Follow Thomas Joyce:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Founder & CEO of swyMed Incorporated
Follow Stefano Migliorisi:
About swyMed Incorporated: swyMed’s solutions power truly mobile, real-time video telemedicine encounters at the lowest bandwidths.
CEO of Willis Towers Watson
Follow John Haley:
About Willis Towers Watson: Willis Towers Watson is a global advisory and solutions company that helps clients around the world turn risk into a path for growth.
CEO of Kardium
Kevin Chaplin is the CEO at Kardium.
Follow Kevin Chaplin:
About Kardium: Kardium develops medical devices for the diagnosis and treatment of atrial fibrillation.
President & CEO of Zymeworks
Ali Tehrani is one of Zymeworks’ co-founders and currently serves as President and CEO of the company. He has been an integral part of many of the Company’s corporate achievements including raising seed and angel financing and overseeing the Company’s technical operations and patent filings. Dr. Tehrani has served on the MITACS Industrial Advisory Board, and BIOTECanada’s Industrial and Environmental Committee. Currently, he is a member of the Board of Directors of LifeSciences British Columbia and the Student Biotechnology Network.
Follow Ali Tehrani:
About Zymeworks: Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Founder & CEO of LCA Vantage
Vincent Lopez is a Mexican-American entrepreneur, and the founder & CEO of LCA Corp., which manages investments in various industries, including healthcare, technology, and media. Mr. Lopez is the founder & CEO of LCA Vantage Healthcare, a transformative cost-saving market-disrupting solution to America’s crippling healthcare system. Throughout his career, Mr. Lopez has held several esteemed positions including a 2015 nomination by Governor Tom Wolf (D-PA) to the Pennsylvania State System of Higher Education, Board of Governors. He completed a Fellowship in STEM (Science, Technology, Engineering, & Math) education targeted in minority neighborhoods, with President Obama’s Organizing for Action. He’s served as a law enforcement officer. He’s worked for the U.S. Department of Homeland Security. Subsequently, he went on to work for notable U.S. Government Contractors. He is the founder & CEO of the Lopez Foundation, Inc., a 501 (c)(3) non-profit, which focuses on establishing lifelong success in our schools, communities, and our working world. The Foundation believes in its core principles to “Teach, Inspire, Empower, & Lead” the next generation. He studied at the Indiana University of Pennsylvania, where he majored in English, political science, and government (Pre-law). He’s an avid fan of Formula 1 racing, horse racing, and fishing.
Follow Vincent Lopez:
About LCA CORP, LCA Vantage, The Lopez Foundation,Inc.: Electronic Health Records, Remote Physiological Monitoring, Biometrics, FHIR Complaint, Health Subscriptions
Founder & CEO of Vianova Health
Farhad is a CEO and Co-Founder of Vianova Health, which is a company reinventing home care. We personalize the technology and daily engagement to remotely care for your patients. Our Remote Health platform. Better health is defined by what a patient does at home between visits. [email protected] makes the difference.
Follow Farhad Chowdhury:
About Vianova Health: Vianova Health is reinventing home care. We personalize the technology and daily engagement to remotely care for patients
President & CEO/cofounder of Kintara Therapeutics
Jeffrey Bacha, BSc, MBA co-founded DelMar Pharmaceuticals in 2010 and has served as Chief Executive Officer and Chairman of the Company’s board of directors since inception. Mr. Bacha is a seasoned executive leader with nearly twenty years of life sciences experience in the areas of operations, strategy and finance. His background includes successful public and private company building from both a start-up and turn around perspective; establishing and leading thriving management and technical teams; and raising capital in both the public and private markets. From July 2006 to August 2009, Mr. Bacha was Executive Vice President Corporate Affairs and Chief Operating Officer at Clera, Inc. From March 2005 to July 2006 Mr. Bacha was Consultant and held various positions at Clera Inc., Urigen Holdings Inc. and XBiotech, Inc. From 1999 through 2004, Mr. Bacha served as President & CEO of Inimex Pharmaceuticals, a venture-capital funded drug discovery and development company and is a former Senior Manager and Director of KPMG Health Ventures. Mr. Bacha holds an MBA from the Goizueta Business School at Emory University and a degree in BioPhysics from the University of California, San Diego.
Follow Jeffrey Bacha:
About Kintara Therapeutics: Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.
Co-founder & CEO of PocketPills
Raj Gulia is a Co-Founder at PocketPills.
Follow Raj Gulia:
About PocketPills: Pocketpills is Canada’s leading online pharmacy, delivers medication by the dose, straight to customer’s door.
President and CEO of Medicenna Therapeutics
Fahar Merchant is a 25-year biotech veteran, a serial entrepreneur and co-founder of Medicenna. Previously he was President and CEO of Protox Therapeutics (TSX.V and TSX; now Sophiris Bio, Nasdaq) where he established a late clinical stage urology company. At Protox he raised more than $70M through multiple PIPEs, including a $35M investment by Warburg Pincus. In 1992 he co-founded IntelliGene Expressions, Inc., a biologics CDMO, and built it to one of the fastest growing companies in Canada. In 2000, by strategic in-licensing, he co-founded Avicenna Medica, Inc., a clinical stage oncology company that was sold a year later to KS Biomedix (LSE) for $90M. Fahar was CTO and Director of KS Biomedix until its acquisition by Xenova (Nasdaq and LSE; now Celtic Pharma). Fahar has closed several transactions valued at more than $300M. He has a PhD in Biochemical Engineering from Western University.
Follow Fahar Merchant:
About Medicenna Therapeutics: Medicenna is a clinical stage, privately held, immuno-oncology company.
CEO of AbCellera Biologics
Carl Hansen is the CEO at AbCellera.
Follow Carl Hansen:
About AbCellera Biologics: AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.
President and CEO of Emmes
Anne Lindblad is the president and CEO of The Emmes Corporation. She joined the Emmes in the early years of the company when he was recruited in 1982 by its former CEO, Don Stablein. Anne holds a Ph.D. from George Washington University, M.S. from Medical College of Virginia, and B.S. from Hollins College.
Follow Anne Lindblad:
About Emmes: Emmes is a clinical research collaborator.
CEO of MAI
Follow Sam Jang:
About MAI: MAI specializes in the field of medical VR innovations to create maps of the human body.
CEO, Founder & Chairman of HealthCubed
Ramanan is an international public health veteran and a leading global expert on the understanding of antibiotic resistance as a problem of managing a shared global resource. He realized an unmet need for a product that can address public health challenges of the world. The key characteristics of this product were that it had to be easy to use, quick and affordable. HealthCubed was born to address this need. Ramanan, is also an economist, engineer and epidemiologist by training and is the director and Senior Fellow at the Center for Disease Dynamics, Economics & Policy (CDDEP) in Washington, D.C., and the Senior Research Scholar and Lecturer at Princeton University. He has served on the U.S. President’s Council of Advisors on Science and Technology’s antimicrobial resistance working group and is a voting member of the U.S. Presidential Advisory Council on Combating Antimicrobial Resistance. He is a series editor of the Disease Control Priorities for Developing Countries, 3rd edition. In 2012, Ramanan created the Immunization Technical Support Unit that supports the immunization program of the Ministry of Health and Family Welfare of the Government of India and which is credited with helping rapidly improve vaccination coverage and the introduction of new vaccines. As Vice President, Research and Policy at the Public Health Foundation of India between 2011 and 2015, he led the growth of a research division from 80 to over 700 technical and research staff. Whenever he has some time he would be either working on his new book or spending time with his family.
Follow Ramanan Laxminarayan:
About HealthCubed, Princeton University: HealthCubed is a portable diagnosis system that can be used easily anywhere by anyone.
Founder,CEO & President of Calgary Scientific
CEO of PureWeb Inc. (Formerly Calgary Scientific Inc.), Co-Founder and Chairman of Zolo. Prior to founding Zolo, Barry was active in the VC and Start-up community as Entrepreneur In Residence for Ventures West, Creative Destruction Labs Vancouver and Calgary, Founder of BC Excels Program and Accredited Lead Mentor for BC Innovation Council. The majority of his career was spent building high tech public companies including building VSM MedTech from 2 employees to 200 and $360mm market cap on the TSX.
Follow Barry Allen:
About Calgary Scientific, Creative Destruction Lab (CDL), Zolo Realty: Calgary Scientific develops web and mobile diagnostic medical imaging solutions and collaboration enablement technologies.
Co-founder, President and CEO of AMP3D
Kevin joined Pong Research in January of 2011. Prior to Pong, Kevin was a partner in Harvest Equity Partners, LLC in Middleburg, Virginia—a $60M private equity management and advisory firm. From 1999 until 2005, Kevin served as Vice President, General Counsel and COO of TRADOS Incorporated, a software company with 9 worldwide offices. TRADOS was backed by Microsoft and Sequoia Capital, and was acquired by SDL plc for $60 million. Kevin helped to transform the company from a desktop license outfit to an enterprise software player providing “global information services” and “multi-lingual content management” solutions to Fortune 500 customers. Kevin was formerly Senior Counsel International at Fulbright & Jaworski LLP in Washington, and previously maintained his own boutique corporate finance practice in the Pittsburgh area. Kevin was graduated from Georgetown University Law Center in 1986, and from Saint Vincent College in 1983 with a major in Philosophy and minor in Ancient Languages. Kevin has remained an active member of various business organizations and networks, including as a director of various private companies and charities as well as on the executive committee of Saint Vincent College. Kevin’s interests include travel, reading, skiing, golf and music. Kevin and his wife live in Middleburg, Virginia and have three children.
Follow Kevin Passarello:
About AMP3D, Buchanan Ingersoll & Rooney PC: AMP3D’s extensible SaaS platform for predictive analytics processes “Big” physiological monitoring Data in real time.
Mary Ellen Beliveau
Founder & CEO of Knowledge to Practice
Mary Ellen Beliveau is the Founder & CEO at Knowledge to Practice.
Follow Mary Ellen Beliveau:
About Knowledge to Practice: Transforming postgraduate medical education, delivering personalized, just in time learning for time starved MD’s
Co-Founder & Chief Executive Officer of Lazy
Follow Chris Millet:
About Lazy: Lazy offers an API for quality measurement and improvement through medical billing companies and medical record companies.
Executive Director and Chief Executive Officer of Medical Association of Georgia
Follow Jeremy Bonfini:
About Medical Association of Georgia: Medical Association of Georgia focuses on legislative and legal and third-party payer issues.
Chairman and CEO of Clarius Mobile Health
Follow Laurent Pelissier:
About Clarius Mobile Health: Clarius is developing a novel medical imaging ecosystem.
Founder and CEO of Mindful Garden
Catherine Winckler currently works as Founder and Chief Executive Officer at Mindful Garden.
Follow Catherine Winckler:
About Mindful Garden: Mindful Garden develops a behaviour modification platform to de-escalate anxiety and aggression of patients with chronic disease.
Founder & CEO of Tenzr Health
Lukas has four years of startup experience and is well network with VR|AR partners, R&D institutions and government funds. BIT is his second startup.
Follow Lukas-Karim Merhi:
About Tenzr Health: Technology-driven Motivation, Guidance, and Certainty for Musculoskeletal Care
CEO of Nanovis
Matt Hedrick is the chief executive officer of Nanovis.
Follow Matt Hedrick:
About Nanovis: Nanovis is a technology-driven growth company that develops cervical and lumbar interbody fusion devices.
Joshua S. Benner
President & Chief Executive Officer of RxAnte
Josh Benner is the President and CEO at RxAnte.
Follow Joshua S. Benner:
About Harvard Innovation Labs, RxAnte: RxAnte offers predictive analytics and targeted clinical programs that improve medication prescribing and adherence.
Founder, President & CEO of Canary Medical
Dr. Hunter has been a member of Cardiome’s Board of Directors since 2007 and became the Company’s Interim President and CEO in July, 2012. Prior to Cardiome, Dr. Hunter co-founded Angiotech Pharmaceuticals in 1992 and assumed the position of Chief Executive Officer in 1997 when Angiotech was a venture-stage, private, pre-clinical company with less than 50 employees. He led Angiotech through 3 rounds of private equity financing, the Company’s IPO and listing on the Toronto Stock Exchange and NASDAQ, over $1B in equity and debt financings, a debt restructuring and 8 separate corporate acquisitions. During that time, Angiotech grew to become a profitable, diversified, healthcare company with over 1,400 employees, several thousand commercially available products, 12 facilities in 5 countries and worldwide annual revenues exceeding $250M. Dr. Hunter has over 200 patents and patent applications to his name and products in which he was an inventor or co-inventor include the TAXUS® Drug-Eluting Coronary Stent, the Zilver PTX Peripheral Drug-Eluting Stent, the Quill barbed wound closure device and the 5-FU Anti-Infective Catheter; combined these products have been used in over 6 million patients and recorded revenues of over $12 billion worldwide. Dr. Hunter currently serves a director of Zalicus Inc (NASDAQ: ZLCS) and Union Medtech and selected awards he has received include the 2006 Principal Award from the Manning Foundation (one of Canada’s highest awards for innovation); BC Innovation Council’s Cecil Green Award for Science and Technology Entrepreneurship; Entrepreneur of the Year from the Canadian Venture Capital and Private Equity Association; and Canada’s 40 Under 40. Dr. Hunter served as a practicing physician in British Columbia for 5 years
Follow William Hunter:
About Canary Medical, Cardiome Pharma: Vancouver-based medical data firm.
President & CEO of BioFactura
Follow Darryl Sampey:
About BioFactura: BioFactura is a biopharmaceutical research and manufacturing company
President & CEO of Welichem Biotech
Dr. Liren Tang has been the President and CEO of the Company since November 2009. From 2007-2009, as the Director of Clinical Development at the Company, Liren led a clinical research team to the successful completion of multiple clinical trials. With the compelling clinical data, the Company reached a successful partnering agreement for it’s lead immunology drug program (WBI-1001) with GlaxoSmithKline (GSK) for a total price of up to $230 million dollars in the year 2012. Prior to joining Welichem, Liren was a principal or co-principal investigator at the Vancouver Coastal Health Research Institute for diverse scientific and clinical research projects addressing various aspects of inflammatory diseases and cancers. He is an author of over 30 peer-reviewed scientific publications. Liren received his PhD in Cell and Developmental Biology at the University of British Columbia.
Follow Liren Tang:
About Welichem Biotech: Welichem Biotech is a development stage biotechnology company, engages in the discovery and development of therapeutic drugs.
Founder , President & Chief Executive Officer of FTL Global Solutions
Moe Abutaleb is cofounder of UltiSat and a seasoned executive involved in various segments of the telecommunications industry since 1977. Throughout his career, Moe has participated in and managed the definition, development, and implementation of numerous satellite and wireless communications networks and products. In addition, he has held senior management positions with leaders in the satellite communications and aerospace industries. Abutaleb cofounded Innovative Communications Technologies, Inc. (ICTI) in 1989. As president of ICTI, he managed the systematic and progressive growth of this self-financed start-up, including the sale of ICTI to a publicly traded corporation in 1999. In 2011, Abutaleb was presented with the Tech Council of Maryland’s prestigious Executive of the Year Award. Abutaleb is a coauthor on several patents and holds a MSEE degree, with emphasis in communications and microelectronics.
Follow M.G. Abutaleb:
About FTL Global Solutions: FTL is a leading provider of scalable, sustainable and secure solutions for humanity.
Founder & CEO of OneTeamVisi
Kent Lewis is a leader and a veteran of the direct sales industry with more than 20 years of global marketing and operations experience. He has directed successful international development strategies for major direct sales companies, which includes work in more than 30 countries. Kent has an ability to analyze international markets and identify key factors for success. He has lived in Japan and speaks, reads, and writes Japanese. Kent received a Bachelor of Science in Psychology and Japanese from Brigham Young University and a Global Master of Business Administration from Thunderbird, the number-one ranked international business school.
Follow Kent Lewis:
About OneTeamVisi: Centered on the powerful benefits of Scandinavian nature including the Arctic Cloudberry.
CEO of California Healthcare Institute
Todd E. Gillenwater was appointed interim President and CEO of CHI-California Healthcare Institute January 2014 and currently oversees all CHI operations. Gillenwater first joined CHI as Vice President-Public Policy in March 2004. December 2010, Gillenwater was promoted to Senior Vice President – Public Policy. In that capacity, Gillenwater was responsible for managing CHI’s Washington, D.C. office where he directed the organization’s federal government relations advocacy and outreach activities across issues including U.S. Food and Drug Administration (FDA) and Medicare policies, intellectual property, science research funding, science and math education and tax policy. Prior to joining CHI, Gillenwater was Legislative Director for Congressman David Dreier (R-California), Chairman of the House Rules Committee. In that position, Gillenwater guided the congressman’s legislative work in major policy areas including healthcare, tax policy, and science and technology. In particular, he worked on Medicare, drug importation, stem cell research, NIH funding, and other legislative issues relevant to the biotechnology, pharmaceutical, medical device and academic research communities. Prior to serving on Rep. Dreier’s staff, Gillenwater was an Associate at The Heritage Foundation. Gillenwater holds a master’s degree in management from the Catholic University of America in Washington D.C., and a bachelor’s degree in international relations from Georgia Institute of Technology in Atlanta.
Follow Todd Gillenwater:
About California Healthcare Institute, Medtronic: CHI represents over 275 biotech, medical device, diagnostics, pharma companies, public & private academic biomed research orgs.
President & CEO of The National Electrical Manufacturers Association
Kevin Cosgriff is President & CEO of the National Electrical Manufacturers Association headquartered in Arlington, Virginia. The 400+ member companies of NEMA manufacture a full range of diverse products used in generation, transmission, distribution and end use of electricity as well as medical diagnostic imaging. Before retiring then Vice Admiral Cosgriff was Commander, U.S. Naval Forces Central Command where he oversaw all naval combat, combat support, and maritime security operations throughout the Middle East and Southwest Asia area, including Iraq, Afghanistan and the Horn of Africa areas. He simultaneously commanded the U.S. Fifth Fleet and the Combined Maritime Forces, the latter comprised of ships and aircraft from over twenty contributing nations. He fashioned an operational approach to provide multi-lateral maritime security in this energy-rich area covering three vital waterways. Working with U.S. Ambassadors and local leaders, he led efforts to enhance the capability and capacity of regional navies and coast guards. Through direct personal interaction with Ministers and Heads of militaries and navies, he forged strong relationships between the U.S. Navy and these important countries. Vice Admiral Cosgriff was previously the Deputy Commander, U.S. Fleet Forces Command in Norfolk, Virginia. Before that he served as Director for Warfare Analysis and Integration for the Chief of Naval Operations, and was the Director, Office of Program Appraisal for the Secretary of the Navy. During the Clinton Administration, he was the Director, White House Situation Room and Director of Systems and Technical Planning for the National Security Council. Vice Admiral Cosgriff served as Executive Assistant to the Under Secretary of the Navy, and earlier was Deputy Director of the Chief of Naval Operations Executive Panel. He was Assistant Director for House of Representatives Liaison in the Office of Legislative Affairs and had served as Executive Assistant to Navy’s Director of Strategy and Policy. He was also an analyst at the Defense Intelligence Agency/National Military Intelligence Center. In addition to the U.S. Fifth Fleet, Vice Admiral Cosgriff previously commanded Cruiser Destroyer Group Eight/Theodore Roosevelt Battle Group. He commanded Destroyer Squadron 32 and USS Robert G Bradley (FFG 49) earlier in his career. He graduated from the U.S. Merchant Marine Academy at Kings Point, N.Y. and began active duty with the Navy directly thereafter. He was among the first students to receive a Master of Science in Strategic Intelligence from the National Intelligence University, on which Board of Visitors he now serves. He also is on the Board of the Applied Physic Laboratory of the University of Washington and at the Stimson Center, a Washington DC think tank.
Follow Kevin Cosgriff:
About The National Electrical Manufacturers Association: NEMA is the association of electrical equipment and medical imaging manufacturers, founded in 1926 and headquartered in Rosslyn, Virginia.
Co-CEO and Co-Founder of Ibex Biosciences
Murat Croci is a Co-CEO, Operations & Strategy, and Co-Founder of Ibex Biosciences.
Follow Murat Croci:
About Ibex Biosciences: Ibex Biosciences engages in a diverse approach to research and development.
Co-Founder and CEO of Claris Healthcare
Geof Auchinleck has more than 35 years of experience in the medical device field. He was part of the Vancouver-based team that built and tested the world’s first robot specifically designed to assist in surgery, then went on to develop a number of other surgical technologies, including surgical tools for laparoscopic surgery, surgical limb positioning, blood sample handling equipment, apparatus for total knee arthroplasty, and surgical drapes. In 1997, Geof cofounded Neoteric Technology Ltd. Neoteric developed and commercialized technologies for ensuring the correct storage, tracking, handling and administration of blood for transfusion in hospitals. This technology, BloodTrack®, is now in daily use in hospitals all over the world. In 2009, Neoteric Technology Ltd. was acquired by Haemonetics Corporation of Braintree, Massachusetts (NYSE:HAE). Geof left Haemonetics in 2011.
Follow Geof Auchinleck:
About Claris Healthcare, Creative Destruction Lab (CDL): Claris Healthcare is medical technology company that provides SaaS Remote Patient Monitoring and Rehabilitation.
Chief Executive Officer of Arbutus Medical
BC Business 30under30 winner in 2020. Masters in biomed engineering from UBC. Orthopaedic research background. Held position as Director of Operations for Arbutus Medical from 2014-2018.
Follow Lawrence Buchan:
About Arbutus Medical: Simple orthopaedic power tools that save cost for hospitals.
Staf van Cauter
President & CEO of Bioscan
Follow Staf van Cauter:
About Bioscan: Bioscan develops instrumentation for the detection, synthesis, and imaging of radio-labeled compounds used in several fields.
CEO of Genetron Health
Follow Sizhen Wang:
About Genetron Health: Genetron Health is a world-leading expert in precision medicine.
Co-Founder & CEO of Current Surgical
Al Mashal currently works as the Co-Founder and CEO for Current Surgical.
Follow Al Mashal:
About Current Surgical: Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors.
William P. Leonard
Founder & CEO of TMS NeuroHealth Centers Tysons Corner
As Founder and CEO of Greenbrook TMS NeuroHealth Centers, Bill Leonard is pioneering the accessibility of Transcranial Magnetic Stimulation Therapy (TMS), a revolutionary medical treatment for individuals suffering with Major Depressive Disorder (MDD). Bill has assembled a medical team of leading practitioners in the fields of neurology and psychiatry to provide patients with cutting-edge treatment and compassionate care. For more than 20 years, Bill has provided operational and strategic leadership in the development of medical devices, pharmaceuticals and healthcare services. As President of the Bio-Pharmaceutical Division for Euclid Vision Corporation, Bill procured FDA strategy for an ophthalmic drop that was successfully approved to undergo clinical trials. Bill also served as President of TLC Vision Refractive Surgery Division (TLC), the leading provider of ophthalmic refractive surgery services in the United States. At TLC, Bill piloted a comprehensive business strategy and leadership generating over 200 million dollars in revenue with 900 employees, and a client base of 13,000 eye care professionals.
Follow William P. Leonard:
About TMS NeuroHealth Centers Tysons Corner: TMS NeuroHealth Centers Tysons Corner provides transcranial magnetic stimulation therapy for the treatment of neurological diseases.
CEO of Green Leaf Medical
Follow Philip Goldberg:
About Green Leaf Medical: Green Leaf is a medical cannabis cultivator that provides patients with safe access to medical cannabis in a variety of administrations.
President and CEO of Diagnostic Medical Imaging
Dr. Narang is currently the president and CEO of Diagnostic Medical Imaging and Clinical Radiologists Medical Imaging, a radiology practice in Silver spring, MD. He is a graduate of Des Moines University and completed radiology residency training at Howard University Medical Center, with further training at George Washington University Medial Center in Neuroradiology. He has served on the faculty of both GW Medical Center and Georgetown Univ Medical Center. He is a diplomate of the American Board of Radiology and a fellow of the American College of Radiology. He has served in various leadership positions with the American College of Radiology including a tenure as President of the Wash DC chapter. He has authored articles in the field of radiology and spoken at numerous scientific meetings
Follow Anil Narang:
About Clinical Radiologists, Diagnostic Medical Imaging, Georgetown University: Diagnostic Medical Imaging, LLC is a multi-modality imaging center with multiple locations throughout Florida
President & CEO of Nu-Pulse
Weithers is the founder, CEO, and President of Nu-Pulse Technologies Inc, providing integrated security and risk management solutions. Under his leadership since 1998, Nu-Pulse has successfully completed projects for various levels of government, as well as commercial customers in the retail, airline, transportation, construction, education and healthcare industries. Mr. Weithers holds a Master’s Degree in Computer Science Engineering from Howard University. Moreover, his expertise in the areas of Information Technology, Fire Protection Engineering, Physical and Cyber Security, Access Control, Intrusion detection and prevention, and Construction has resulted in many certifications and awards, including television appearances. Mr. Weithers is a seminar speaker, has made multiple appearances on local cable television, and has been quoted in national industry magazines and publications where he discussed technology advances in local government and the commercial sectors. He has served as a member of the EDI standards committee for the major cable programming networks, and has participated in the re-engineering of standards for major billing systems. Mr. Weithers has over thirty one years of combined Management and Design experience with Security, Information Technology and Telecommunications Systems projects, including 8 years as a Chief Information Officer. He holds construction licenses in multiple states.
Follow Patrick Weithers:
About ARCG, Nu-Pulse: NuPulse is a medical device company developing novel technology to treat patients with heart failure.
CEO of Centerline Biomedical
Follow jai gupta:
About : Centerline Biomedical, a Cleveland Clinic spin-off, is developing an innovative system
Co-Founder & CEO of Accelerated Orthopedic Technologies
Thomas is a music lover, who combines a marketing and advertising apporach to delivering content to the end user. A student at Howard University, Thomas has worked with some of the best names in music. A former Rush Communications intern, Thomas was able to study under Russell Simmons and learn the industry and how its changing. This knowledge allowed him to form Onyx Media Group with 3 friends that allow the user to experience a fan and artist interaction like never before.
Follow Tom Wood:
About Accelerated Orthopedic Technologies, Boies Schiller, Elm Street Ventures, Onyx Media Group: Accelerated Orthopedic Technologies developed tools for obtaining, shaping and implanting cartilage grafts.
CEO and President of Corporation for National Research Iniciatives
Robert E. Kahn is Chairman, CEO and President of the Corporation for National Research Initiatives (CNRI), which he founded in 1986 after a thirteen year term at the U.S. Defense Advanced Research Projects Agency (DARPA). CNRI was created as a not-for-profit organization to provide leadership and funding for research and development of the National Information Infrastructure. After receiving a B.E.E. from the City College of New York in 1960, Robert Kahn earned M.A. and Ph.D. degrees from Princeton University in 1962 and 1964 respectively. He worked on the Technical Staff at Bell Laboratories and then became an Assistant Professor of Electrical Engineering at MIT. He took a leave of absence from MIT to join Bolt Beranek and Newman, where he was responsible for the system design of the Arpanet, the first packet-switched network. In 1972 he moved to DARPA and subsequently became Director of DARPA’s Information Processing Techniques Office (IPTO). While Director of IPTO he initiated the United States government’s billion dollar Strategic Computing Program, the largest computer research and development program ever undertaken by the federal government. Robert Kahn conceived the idea of open-architecture networking. He is a co-inventor of the TCP/IP protocols and was responsible for originating DARPA’s Internet Program. Robert Kahn also coined the term National Information Infrastructure (NII) in the mid 1980s which later became more widely known as the Information Super Highway.
Follow Robert Kahn:
About Corporation for National Research Iniciatives: Corporation for National Research Iniciatives
Chief Executive Officer of Blue Star Service Solutions
A Mechanical Engineer from the Naval Academy, Admiral Wray spent seven years of active duty as a nuclear engineer on surface ships, carriers, and submarines. Transferring to the reserves, he enjoyed a varied 20-year career in business, in manufacturing, hospitality, technology, consulting, and construction. After mobilization to Baghdad, he was promoted to Admiral, and placed back on active duty for the past six years. He recently retired as a two star. He has a Masters from Georgetown University, is a licensed professional engineer, holds a patent, has written two books, and is a frequent professional speaker on leadership and management. He has 14 present or former service members in his family, 4 of which are aged 80 or older.
Follow Robert Wray:
About Blue Star Service Solutions: Blue Star Service Solutions operates as a medical alert system production company.
Chair of the Board and Chief Executive Officer of AnthroTronix
PhD in Neuroscience and MS in Aeronautics and Astronautics, Massachusetts Institute of Technology. Since 1999, Co-Founder, Board Chair and Chief Executive Officer, AnthroTronix, a biomedical engineering research and development company and leader in digital healthcare technology. Member of the Board: Engineering World Health; National Black Child Development Institute; KID-Museum Maker Space. Technology Pioneer, Young Global Leader, and Chair, Global Agenda Council for AI and Robotics, World Economic Forum. Work on advanced human-technology interfaces for robotics and mobile technology platforms has been featured in Forbes, Time and the New Yorker magazines. Named one of Fast Company’s Most Creative People in Business.
Follow Corinna Lathan:
About AnthroTronix: AnthroTronix is an award-winning research and development (R&D) company.
Founder & CEO of Healthcelerate
Peter is a recognized leader in health IT transformation, information security and regulatory compliance. Among other technology start-ups, he created the first commercial anti-virus product, which became Norton; founded TruSecure and CyberTrust and was Chairman of MD-IT. He was a member of the President’s Information Technology Advisory Committee (PITAC) under G.W. Bush, which drove Health IT transformation policy, and served with both the Clinton Health Matters and the NIH Precision Medicine initiatives. He received the U.S. Chamber’s First Leadership in Health Care Award for his work to improve transparency and reward innovation through the modernization of the exchange of health information technology. He has been recognized by industry publications including InfoWorld, as one of the 25 most influential CTOs in 2002.
Follow Peter Tippett:
About careMESH, Healthcelerate: Healthcelerate is delivering the next generation of secure communications in healthcare.
Founder and CEO of Agartee Technology Inc.
Follow Behzad Behroozan:
About Agartee Technology Inc.: Agartee Vibe System is designed to track and monitor sleep and daily activities to ensure the user is maintaining a healthy lifestyle.